ADAP
Adaptimmune Therapeutics PLC Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website adaptimmune.com
- Employees(FY) 534
- ISIN US00653A1079
Performance
-4.2%
1W
-16.79%
1M
-8.06%
3M
+91.28%
6M
+43.76%
YTD
-18.57%
1Y
Profile
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops SPEARHEAD-1 that is in phase II clinical trials with ADP-A2M4 for synovial sarcoma; SURPASS-3 that is in phase II clinical trial with ADP-A2M4CD8 for people with platinum resistant ovarian cancer; and SURPASS that is in phase I clinical trials in patients with head and neck, and urothelial cancers. The company has strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic and allogeneic T-cell therapies; co-development collaboration agreement with Universal Cells, Inc.; third-party collaborations with Noile-Immune and Alpine Immune Sciences; and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
Technical Analysis of ADAP 2024-05-03
Overview:
In analyzing the technical indicators for ADAP over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2024-05-01 00:00
- 2024-04-22 19:45
Garry Menzel joins GHO Capital as Operating Partner(Globenewswire)
- 2024-04-15 02:12
- 2024-04-11 20:00
- 2024-04-11 17:37
Roche, Adaptimmune part ways on cell therapy research(Yahoo Finance)
- 2024-03-27 07:30
- 2024-03-07 00:42
- 2024-03-06 19:24
- 2024-03-06 19:24
- 2024-03-05 23:52
- 2024-03-05 18:00
- 2024-02-26 19:00
- 2024-02-21 03:00
- 2024-02-15 14:57
15 Top Performing European Stocks So Far in 2024(Yahoo Finance)
- 2024-02-13 05:15
- 2024-01-31 03:44
- 2024-01-30 00:02
- 2024-01-15 22:17
- 2024-01-03 18:37
- 2023-12-05 18:00
- 2023-11-29 21:52
Adaptimmune (ADAP) Rises as GSK Transfers T-Cell Therapy IND(Yahoo Finance)
- 2023-11-28 19:00
- 2023-11-12 20:35
- 2023-11-12 19:35
- 2023-11-07 18:30
- 2023-11-07 18:05
- 2023-11-07 05:15
- 2023-10-30 20:00
- 2023-10-30 20:00
- 2023-10-27 06:15
Page 1 of 4
previousnext